Gong B - Search Results

1

Synaptic fatigue is more pronounced in the APP/PS1 transgenic mouse model of Alzheimer's disease.

Zhang H, Gong B, Liu S, Fa' M, Ninan I, Staniszewski A, Arancio O. Zhang H, et al. Among authors: gong b. Curr Alzheimer Res. 2005 Apr;2(2):137-40. doi: 10.2174/1567205053585936. Curr Alzheimer Res. 2005. PMID: 15974910

2

Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory.

Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, Moolman D, Zhang H, Shelanski M, Arancio O. Gong B, et al. Cell. 2006 Aug 25;126(4):775-88. doi: 10.1016/j.cell.2006.06.046. Cell. 2006. PMID: 16923396 Free article.

3

Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.

Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, Arancio O. Gong B, et al. J Clin Invest. 2004 Dec;114(11):1624-34. doi: 10.1172/JCI22831. J Clin Invest. 2004. PMID: 15578094 Free PMC article.

4

Reversal of long-term dendritic spine alterations in Alzheimer disease models.

Smith DL, Pozueta J, Gong B, Arancio O, Shelanski M. Smith DL, et al. Among authors: gong b. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16877-82. doi: 10.1073/pnas.0908706106. Epub 2009 Sep 14. Proc Natl Acad Sci U S A. 2009. PMID: 19805389 Free PMC article.

5

Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J.

Vitolo O, Gong B, Cao Z, Ishii H, Jaracz S, Nakanishi K, Arancio O, Dzyuba SV, Lefort R, Shelanski M. Vitolo O, et al. Among authors: gong b. Neurobiol Aging. 2009 Feb;30(2):257-65. doi: 10.1016/j.neurobiolaging.2007.05.025. Epub 2007 Jul 20. Neurobiol Aging. 2009. PMID: 17640772 Free PMC article.

6

Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease.

Gong B, Levine S, Barnum SR, Pasinetti GM. Gong B, et al. Curr Alzheimer Res. 2014;11(7):637-44. doi: 10.2174/1567205011666140812113707. Curr Alzheimer Res. 2014. PMID: 25115545 Review.

7

SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function.

Gong B, Chen F, Pan Y, Arrieta-Cruz I, Yoshida Y, Haroutunian V, Pasinetti GM. Gong B, et al. Aging Cell. 2010 Dec;9(6):1018-31. doi: 10.1111/j.1474-9726.2010.00632.x. Epub 2010 Oct 29. Aging Cell. 2010. PMID: 20854419 Free PMC article.

8

Cocoa extracts reduce oligomerization of amyloid-β: implications for cognitive improvement in Alzheimer's disease.

Wang J, Varghese M, Ono K, Yamada M, Levine S, Tzavaras N, Gong B, Hurst WJ, Blitzer RD, Pasinetti GM. Wang J, et al. Among authors: gong b. J Alzheimers Dis. 2014;41(2):643-50. doi: 10.3233/JAD-132231. J Alzheimers Dis. 2014. PMID: 24957018

9

Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease.

Ho L, Ferruzzi MG, Janle EM, Wang J, Gong B, Chen TY, Lobo J, Cooper B, Wu QL, Talcott ST, Percival SS, Simon JE, Pasinetti GM. Ho L, et al. Among authors: gong b. FASEB J. 2013 Feb;27(2):769-81. doi: 10.1096/fj.12-212118. Epub 2012 Oct 24. FASEB J. 2013. PMID: 23097297 Free PMC article.

10

IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C/EBP signaling pathway.

Gong B, Pan Y, Zhao W, Knable L, Vempati P, Begum S, Ho L, Wang J, Yemul S, Barnum S, Bilski A, Gong BY, Pasinetti GM. Gong B, et al. Among authors: gong by. Mol Immunol. 2013 Dec;56(4):619-29. doi: 10.1016/j.molimm.2013.06.016. Epub 2013 Aug 1. Mol Immunol. 2013. PMID: 23911420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,657 results

Search Page

Filters